Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.43 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.17.
Market Cap
9.43T
Revenue
4.67T
Profits
187.96B
PE Ratio
50.17
Profit Margin
4.03%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.88% | 2,220,271 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 663.28B | -1.15% | 4,320,883 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 453.19B | -1.44% | 4,729,745 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 370.89B | -1.32% | 4,397,469 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 356.47B | -0.95% | 5,566,395 | 450.53B |
| 6 | NVS | Novartis AG | 304.21B | -1.90% | 1,294,325 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.79B | -1.26% | 3,072,847 | 61.37B |
| 8 | AMGN | Amgen Inc. | 236.38B | -1.55% | 1,656,100 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 226.94B | -0.75% | 1,229,017 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 205.51B | -1.92% | 6,216,381 | 50.34B |
| 11 | ABT | Abbott Laboratories | 187.45B | -0.42% | 7,029,311 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 187.23B | -0.15% | 6,181,492 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.16B | -1.25% | 23,791,957 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.98B | -1.60% | 2,898,106 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.42B | -2.12% | 803,554 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.49B | -1.87% | 4,825,357 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 129.55B | -0.85% | 2,081,166 | 11.03B |
| 18 | CVS | CVS Health Corporation | 123.73B | -0.47% | 4,498,438 | 412.65B |
| 19 | MDT | Medtronic plc | 120.46B | 1.15% | 9,013,365 | 37.54B |
| 20 | SYK | Stryker Corporation | 116.27B | -1.58% | 2,401,419 | 25.84B |
| 21 | SNY | Sanofi | 106.18B | -0.20% | 1,694,943 | 55.89B |
| 22 | MCK | McKesson Corporation | 105.86B | -1.45% | 879,220 | 410.98B |
| 23 | GSK | GSK plc | 100.04B | -1.93% | 2,287,080 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 88.37B | -1.76% | 1,132,914 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 87.68B | -1.03% | 971,433 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.65B | -1.87% | 561,087 | 15.53B |
| 27 | CI | The Cigna Group | 74.65B | -1.31% | 1,204,726 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.27B | 1.81% | 15,503,015 | 21.00B |
| 29 | ARGX | argenx SE | 64.94B | -1.93% | 125,040 | 5.32B |
| 30 | COR | Cencora, Inc. | 63.15B | -1.86% | 1,027,599 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.86B | -1.39% | 1,499,546 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.11B | -2.23% | 14,966,548 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 57.49B | -0.58% | 1,548,350 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.82B | 0.13% | 2,635,273 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 50.32B | -1.54% | 1,439,097 | 22.48B |
| 36 | HUM | Humana Inc. | 48.22B | -1.23% | 783,089 | 145.68B |
| 37 | MDLN | Medline Inc. | 48.11B | - | 5,172,201 | 29.94B |
| 38 | NTRA | Natera, Inc. | 47.31B | 0.16% | 968,016 | 2.71B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.01B | -0.40% | 884,139 | - |
| 40 | VEEV | Veeva Systems Inc. | 44.54B | -3.27% | 1,152,296 | 3.46B |
| 41 | IQV | IQVIA Holdings Inc. | 44.07B | -1.42% | 1,197,936 | 16.98B |
| 42 | A | Agilent Technologies, Inc. | 42.53B | 0.59% | 1,825,227 | 7.37B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 42.37B | -0.71% | 7,402,512 | 17.32B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 42.18B | 1.15% | 407,862 | 4.55B |
| 45 | HLN | Haleon plc | 42.02B | -2.64% | 18,166,342 | 14.80B |
| 46 | ONC | BeOne Medicines AG | 40.73B | -1.22% | 202,355 | 6.13B |
| 47 | WAT | Waters Corporation | 40.22B | -1.01% | 352,136 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 36.78B | 0.13% | 3,402,547 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.61B | 0.61% | 1,430,922 | 4.80B |
| 50 | ALC | Alcon Inc. | 34.21B | -2.19% | 1,340,992 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.17B | -2.02% | 2,361,538 | 4.97B |
| 52 | CNC | Centene Corporation | 33.12B | -1.44% | 2,926,227 | 180.30B |
| 53 | ILMN | Illumina, Inc. | 32.95B | -1.55% | 1,748,099 | 4.49B |
| 54 | RMD | ResMed Inc. | 32.94B | -0.37% | 843,834 | 5.65B |
| 55 | BIIB | Biogen Inc. | 32.63B | -1.64% | 465,103 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.33B | -0.63% | 4,190,869 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.10B | -1.23% | 2,760,455 | 21.27B |
| 58 | INSM | Insmed Incorporated | 27.58B | -0.31% | 1,802,543 | 1.14B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.95B | -0.81% | 103,029 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 26.51B | -1.39% | 438,649 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.17B | -0.94% | 798,699 | 11.56B |
| 62 | BNTX | BioNTech SE | 26.06B | 0.86% | 626,060 | 3.03B |
| 63 | INCY | Incyte Corporation | 25.69B | -0.98% | 1,035,962 | 5.82B |
| 64 | PHG | Koninklijke Philips N.V. | 25.39B | -0.61% | 455,427 | 20.18B |
| 65 | ROIV | Roivant Sciences Ltd. | 25.23B | 1.51% | 5,240,429 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.93B | -0.81% | 364,084 | 3.33B |
| 67 | STE | STERIS plc | 21.90B | -0.69% | 567,998 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.66B | 0.23% | 2,402,367 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.34B | 0.59% | 557,686 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 20.91B | -0.54% | 326,991 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.09B | -2.35% | 1,002,596 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.39B | -0.35% | 5,732,566 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.71B | -0.86% | 1,325,043 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.77B | -0.21% | 719,519 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.50B | -0.35% | 146,428 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.02B | -0.31% | 321,834 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.82B | -1.71% | 933,448 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.61B | -0.81% | 576,349 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.63B | -0.76% | 1,540,362 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.62B | -0.20% | 1,580,988 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.53B | -0.31% | 1,175,212 | 2.91B |
| 82 | SMMT | Summit Therapeutics Inc. | 14.04B | 2.77% | 6,945,815 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.77B | -1.65% | 738,886 | 4.00B |
| 84 | COO | The Cooper Companies, Inc. | 13.57B | -1.49% | 1,957,065 | 4.23B |
| 85 | BAX | Baxter International Inc. | 13.35B | 1.02% | 3,415,193 | 11.47B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.88B | 0.15% | 2,298,644 | 3.41B |
| 87 | ICLR | ICON Public Limited Company | 12.72B | 0.78% | 796,393 | 8.29B |
| 88 | PEN | Penumbra, Inc. | 12.69B | 0.32% | 174,064 | 1.50B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.65B | -1.14% | 1,728,915 | 14.37B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.51B | -0.51% | 1,010,594 | 1.66B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.50B | -0.28% | 177,171 | 1.28B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.24B | 0.33% | 3,718,004 | 5.02B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.20B | -0.17% | 757,666 | 669.50M |
| 94 | SNN | Smith & Nephew plc | 12.10B | 0.63% | 851,034 | 6.30B |
| 95 | FMS | Fresenius Medical Care AG | 12.08B | 0.85% | 480,309 | 22.19B |
| 96 | CORT | Corcept Therapeutics Incorporated | 12.07B | -1.05% | 604,493 | 830.81M |
| 97 | EHC | Encompass Health Corporation | 12.01B | -0.65% | 517,748 | 6.21B |
| 98 | DVA | DaVita Inc. | 11.73B | 1.28% | 473,713 | 14.01B |
| 99 | TEM | Tempus AI, Inc. | 11.66B | -0.06% | 4,574,981 | 1.43B |
| 100 | TECH | Bio-Techne Corporation | 11.36B | -0.03% | 1,856,309 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.27B | -0.77% | 984,260 | 4.14B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.83B | -0.80% | 438,239 | 776.57M |
| 103 | ABVX | ABIVAX Société Anonyme | 10.61B | 0.66% | 489,813 | 5.67M |
| 104 | KRYS | Krystal Biotech, Inc. | 10.60B | -3.56% | 319,765 | 440.48M |
| 105 | GMED | Globus Medical, Inc. | 10.51B | 0.22% | 1,123,632 | 3.14B |
| 106 | GKOS | Glaukos Corporation | 10.46B | -1.60% | 572,520 | 612.84M |
| 107 | MOH | Molina Healthcare, Inc. | 10.46B | -1.04% | 258,289 | 42.47B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.32B | -0.46% | 112,946 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.23B | -2.06% | 1,058,426 | 3.05B |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.18B | -0.50% | 2,343,587 | 3.50B |
| 111 | AVTR | Avantor, Inc. | 10.13B | -1.45% | 7,654,019 | 6.56B |
| 112 | CYTK | Cytokinetics, Incorporated | 10.11B | -1.66% | 1,096,567 | 67.67M |
| 113 | HSIC | Henry Schein, Inc. | 10.01B | -1.16% | 887,870 | 13.60B |
| 114 | UHS | Universal Health Services, Inc. | 10.00B | 0.26% | 428,895 | 18.11B |
| 115 | OSCR | Oscar Health, Inc. | 9.94B | 0.03% | 3,689,895 | 15.32B |
| 116 | ENSG | The Ensign Group, Inc. | 9.87B | -0.76% | 280,259 | 5.49B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.82B | -0.94% | 171,833 | 7.46M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.76B | 0.09% | 378,565 | 105.00M |
| 119 | IONS | Ionis Pharmaceuticals, Inc. | 9.65B | -0.07% | 2,671,092 | 874.09M |
| 120 | RGEN | Repligen Corporation | 9.46B | -1.19% | 806,062 | 785.10M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.43B | -2.07% | 501,296 | 281.99M |
| 122 | PCVX | Vaxcyte, Inc. | 9.10B | -0.02% | 986,681 | - |
| 123 | QGEN | Qiagen N.V. | 8.99B | -0.89% | 1,922,420 | 2.10B |
| 124 | BRKR | Bruker Corporation | 8.91B | -1.53% | 1,334,168 | 3.50B |
| 125 | IBRX | ImmunityBio, Inc. | 8.56B | -1.34% | 4,330,066 | 165.79M |
| 126 | TXG | 10x Genomics, Inc. | 8.16B | -0.90% | 1,469,470 | 616.91M |
| 127 | IMVT | Immunovant, Inc. | 8.11B | 0.33% | 765,739 | - |
| 128 | ATR | AptarGroup, Inc. | 8.10B | -0.70% | 323,986 | 3.93B |
| 129 | HQY | HealthEquity, Inc. | 7.95B | -2.74% | 432,483 | 1.36B |
| 130 | TGTX | TG Therapeutics, Inc. | 7.94B | -1.28% | 992,941 | 799.54M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.85B | 1.98% | 803,823 | - |
| 132 | TWST | Twist Bioscience Corporation | 7.82B | -3.10% | 901,802 | 431.80M |
| 133 | BLTE | Belite Bio, Inc | 7.80B | 13.16% | 735,467 | - |
| 134 | ALKS | Alkermes plc | 7.73B | -1.66% | 1,051,929 | 1.67B |
| 135 | HNGE | Hinge Health, Inc. | 7.45B | 1.77% | 1,179,523 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.08B | -0.99% | 4,711,319 | 989.61M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.07B | -2.05% | 466,903 | 239.92M |
| 138 | GRFS | Grifols, S.A. | 6.88B | -1.02% | 157,890 | 8.48B |
| 139 | CHE | Chemed Corporation | 6.77B | -0.88% | 84,272 | 2.60B |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.74B | -1.09% | 658,023 | - |
| 141 | PACS | PACS Group, Inc. | 6.73B | -1.32% | 649,463 | 5.55B |
| 142 | CGON | CG Oncology, Inc. | 6.62B | 0.46% | 282,509 | 6.23M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.59B | -0.01% | 828,475 | 1.56B |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | 0.27% | 343,864 | 618.07M |
| 145 | MMED | MiniMed Group, Inc. | 6.54B | -2.33% | 1,719,502 | 3.22B |
| 146 | HIMS | Hims & Hers Health, Inc. | 6.47B | -0.40% | 7,181,866 | 2.58B |
| 147 | BLCO | Bausch + Lomb Corporation | 6.44B | -0.55% | 421,305 | 5.32B |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.15B | -1.89% | 1,050,500 | 591.33M |
| 149 | LQDA | Liquidia Corporation | 6.15B | 0.04% | 902,253 | 450.91M |
| 150 | ORKA | Oruka Therapeutics, Inc. | 6.13B | 1.67% | 600,469 | - |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.08B | -3.18% | 429,467 | 840.85M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.07B | -2.41% | 1,440,947 | 3.12B |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.05B | 0.23% | 638,464 | 1.90M |
| 154 | COGT | Cogent Biosciences, Inc. | 6.03B | -0.54% | 784,063 | - |
| 155 | TFX | Teleflex Incorporated | 5.86B | -1.14% | 464,472 | 2.25B |
| 156 | RDNT | RadNet, Inc. | 5.80B | -1.22% | 497,537 | 2.27B |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.79B | -1.08% | 459,130 | 7.50M |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.78B | -2.94% | 673,537 | 1.01B |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.69B | -1.43% | 132,386 | 290.54M |
| 160 | ERAS | Erasca, Inc. | 5.66B | -0.43% | 2,054,904 | - |
| 161 | STVN | Stevanato Group S.p.A. | 5.60B | -0.15% | 212,892 | 1.40B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.39B | -1.24% | 904,164 | 13.39M |
| 163 | SHC | Sotera Health Company | 5.39B | -0.68% | 1,089,522 | 1.22B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.35B | 1.16% | 599,640 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.12B | 0.24% | 1,128,891 | - |
| 166 | PBLS | Parabilis Medicines, Inc. | 4.99B | -0.81% | 380,617 | 148.00K |
| 167 | LFST | LifeStance Health Group, Inc. | 4.86B | -0.78% | 2,043,757 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.83B | 0.57% | 1,682,948 | 1.14B |
| 169 | WAY | Waystar Holding Corp. | 4.81B | -3.87% | 893,321 | 1.21B |
| 170 | DOCS | Doximity, Inc. | 4.70B | -2.77% | 1,984,657 | 655.57M |
| 171 | BLLN | BillionToOne, Inc. | 4.69B | -0.11% | 976,419 | 397.41M |
| 172 | CELC | Celcuity Inc. | 4.68B | -0.76% | 515,509 | - |
| 173 | HAE | Haemonetics Corporation | 4.68B | 0.07% | 424,674 | 1.35B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | 2.67% | 828,393 | - |
| 175 | DYN | Dyne Therapeutics, Inc. | 4.53B | -2.69% | 1,588,022 | - |
| 176 | LIVN | LivaNova PLC | 4.51B | 0.89% | 334,166 | 1.47B |
| 177 | CON | Concentra Group Holdings Parent, Inc. | 4.40B | -0.12% | 362,550 | 2.29B |
| 178 | NVST | Envista Holdings Corporation | 4.38B | -1.12% | 1,682,108 | 2.86B |
| 179 | ELVN | Enliven Therapeutics, Inc. | 4.35B | -0.55% | 1,113,059 | - |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | 0.80% | 1,610,990 | 1.84B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.28B | 0.41% | 885,468 | -665.00K |
| 182 | HTFL | HeartFlow, Inc. | 4.25B | -1.61% | 1,406,810 | 212.07M |
| 183 | ICUI | ICU Medical, Inc. | 4.19B | 0.78% | 163,492 | 2.16B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.17B | 0.16% | 2,054,838 | 10.35M |
| 185 | LEGN | Legend Biotech Corporation | 4.17B | -1.06% | 812,413 | 1.27B |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.12B | 0.32% | 1,019,384 | 1.33B |
| 187 | MANE | Veradermics, Incorporated | 4.12B | 0.78% | 363,117 | - |
| 188 | VKTX | Viking Therapeutics, Inc. | 4.07B | 2.62% | 1,402,465 | - |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.06B | -0.29% | 444,467 | 825.34M |
| 190 | TLX | Telix Pharmaceuticals Limited | 4.03B | 1.70% | 142,006 | 890.79M |
| 191 | TARS | Tarsus Pharmaceuticals, Inc. | 3.98B | 9.10% | 1,595,936 | 606.33M |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.98B | 1.03% | 8,079,575 | 324.97M |
| 193 | ADPT | Adaptive Biotechnologies Corporation | 3.87B | -1.18% | 1,404,176 | 308.08M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.28% | 448,007 | 234.13M |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.80B | -2.69% | 515,366 | 1.19M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.80B | -1.05% | 1,457,354 | 53.81M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.78B | -1.56% | 736,980 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.70B | -1.21% | 2,019,253 | 66.17M |
| 199 | OPCH | Option Care Health, Inc. | 3.63B | -1.02% | 1,155,613 | 5.69B |
| 200 | OGN | Organon & Co. | 3.62B | 0.07% | 4,872,487 | 6.13B |
| 201 | GRAL | GRAIL, Inc. | 3.59B | -0.35% | 434,817 | 165.26M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.56B | -2.28% | 799,583 | 3.60M |
| 203 | NHC | National HealthCare Corporation | 3.42B | -1.35% | 61,029 | 1.56B |
| 204 | VCYT | Veracyte, Inc. | 3.42B | -4.79% | 992,180 | 561.90M |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.41B | 6.33% | 659,352 | - |
| 206 | GPCR | Structure Therapeutics Inc. | 3.38B | - | 281,703 | - |
| 207 | TMDX | TransMedics Group, Inc. | 3.12B | 3.45% | 542,498 | 668.47M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.12B | 0.79% | 414,529 | 158.00K |
| 209 | QURE | uniQure N.V. | 3.09B | -0.80% | 991,282 | 18.67M |
| 210 | IRON | Disc Medicine, Inc. | 3.04B | -0.18% | 204,813 | - |
| 211 | IMNM | Immunome, Inc. | 3.04B | -1.47% | 562,397 | 4.02M |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 3.04B | -1.74% | 709,503 | 7.12M |
| 213 | WRBY | Warby Parker Inc. | 3.01B | 4.55% | 3,054,450 | 911.61M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 1.01% | 1,631,999 | 463.98M |
| 215 | MBX | MBX Biosciences, Inc. | 2.97B | 0.49% | 271,773 | - |
| 216 | BEAM | Beam Therapeutics Inc. | 2.96B | 0.68% | 1,182,613 | 156.04M |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.96B | -0.44% | 1,843,484 | 2.60B |
| 218 | ZLAB | Zai Lab Limited | 2.94B | -2.85% | 812,771 | 449.61M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.81B | -1.42% | 3,222,760 | 2.93B |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.81B | -0.07% | 5,101,083 | 4.58B |
| 221 | SLS | SELLAS Life Sciences Group, Inc. | 2.80B | 1.17% | 4,526,880 | - |
| 222 | ATAI | AtaiBeckley Inc. | 2.74B | 0.68% | 10,313,858 | 4.47M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.71B | 3.24% | 1,232,071 | 36.77M |
| 224 | PRVA | Privia Health Group, Inc. | 2.64B | -0.05% | 869,321 | 2.36B |
| 225 | CDNA | CareDx, Inc. | 2.63B | 2.05% | 1,307,394 | 458.09M |
| 226 | ATRC | AtriCure, Inc. | 2.62B | -1.79% | 714,569 | 569.62M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | -0.88% | 849,042 | 3.37B |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.60B | -0.17% | 759,913 | 71.13M |
| 229 | AXGN | Axogen, Inc. | 2.60B | 2.51% | 550,025 | 251.17M |
| 230 | VERA | Vera Therapeutics, Inc. | 2.59B | 2.57% | 1,184,640 | - |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 1.59% | 418,369 | 1.46B |
| 232 | NEOG | Neogen Corporation | 2.58B | 1.63% | 1,263,001 | 870.40M |
| 233 | WGS | GeneDx Holdings Corp. | 2.56B | -1.60% | 304,411 | 454.43M |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.55B | -1.29% | 1,475,873 | 940.61M |
| 235 | PGEN | Precigen, Inc. | 2.54B | -0.56% | 2,192,987 | 85.72M |
| 236 | NKTR | Nektar Therapeutics | 2.53B | -2.85% | 613,144 | 54.59M |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.53B | -1.00% | 444,196 | 830.44M |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | -0.21% | 643,515 | - |
| 239 | HCM | HUTCHMED (China) Limited | 2.49B | -0.14% | 150,498 | 549.12M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | -0.57% | 342,843 | 1.10B |
| 241 | PHVS | Pharvaris N.V. | 2.47B | -1.15% | 483,513 | - |
| 242 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 0.93% | 661,470 | 959.90M |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.46B | 1.17% | 856,595 | - |
| 244 | BHC | Bausch Health Companies Inc. | 2.45B | -2.96% | 1,657,597 | 10.85B |
| 245 | NUVB | Nuvation Bio Inc. | 2.39B | 0.59% | 3,755,287 | 169.90M |
| 246 | SRPT | Sarepta Therapeutics, Inc. | 2.38B | -2.13% | 2,869,657 | 1.97B |
| 247 | BHVN | Biohaven Ltd. | 2.37B | -1.07% | 1,901,047 | - |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.34B | - | 1,306,834 | 52.06M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.33B | 1.00% | 1,371,949 | 1.14B |
| 250 | XRAY | DENTSPLY SIRONA Inc. | 2.27B | -0.44% | 2,600,851 | 3.64B |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 1.14% | 162,218 | - |
| 252 | CLOV | Clover Health Investments, Corp. | 2.26B | - | 2,065,894 | 2.48B |
| 253 | UFPT | UFP Technologies, Inc. | 2.24B | 0.79% | 105,030 | 631.64M |
| 254 | NEO | NeoGenomics, Inc. | 2.23B | -0.46% | 997,009 | 766.30M |
| 255 | MESO | Mesoblast Limited | 2.23B | 1.05% | 93,496 | 120.25M |
| 256 | KOD | Kodiak Sciences Inc. | 2.22B | -2.75% | 675,906 | - |
| 257 | ESTA | Establishment Labs Holdings Inc. | 2.21B | 2.75% | 357,360 | 245.82M |
| 258 | RAPP | Rapport Therapeutics, Inc. | 2.20B | -3.95% | 279,874 | 20.00M |
| 259 | ADUS | Addus HomeCare Corporation | 2.17B | 0.06% | 177,117 | 1.48B |
| 260 | URGN | UroGen Pharma Ltd. | 2.16B | -1.76% | 779,039 | 188.73M |
| 261 | ADMA | ADMA Biologics, Inc. | 2.15B | 0.42% | 1,405,858 | 512.28M |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.14B | 0.56% | 532,944 | 1.95B |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.14B | -0.12% | 452,688 | 1.00M |
| 264 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.25% | 526,575 | 311.51M |
| 265 | ALMR | Alamar Biosciences, Inc. | 2.14B | 0.75% | 142,948 | 100.42M |
| 266 | KLRA | Kailera Therapeutics, Inc. | 2.10B | 3.11% | 524,423 | - |
| 267 | GENB | Generate Biomedicines, Inc. | 2.10B | 0.31% | 725,332 | 26.48M |
| 268 | NVCR | NovoCure Limited | 2.09B | 1.70% | 731,976 | 699.19M |
| 269 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | 0.59% | 301,945 | - |
| 270 | ZYME | Zymeworks Inc. | 2.07B | -2.37% | 452,925 | 37.13M |
| 271 | PRGO | Perrigo Company plc | 2.07B | 4.56% | 2,197,092 | 4.14B |
| 272 | VCEL | Vericel Corporation | 2.06B | -0.69% | 312,911 | 306.30M |
| 273 | PGNY | Progyny, Inc. | 1.99B | -2.52% | 1,057,013 | 1.31B |
| 274 | XNCR | Xencor, Inc. | 1.98B | -0.04% | 919,790 | 104.97M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -0.09% | 480,160 | 98.34M |
| 276 | NBTX | Nanobiotix S.A. | 1.97B | -3.00% | 119,297 | 38.27M |
| 277 | ASTH | Astrana Health, Inc. | 1.97B | 1.69% | 241,912 | 3.84B |
| 278 | BFLY | Butterfly Network, Inc. | 1.96B | 0.96% | 3,050,577 | 112.14M |
| 279 | KARD | Kardigan, Inc. | 1.95B | 0.53% | 279,615 | - |
| 280 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | 5.52% | 29,039,059 | 54.86M |
| 281 | GHRS | GH Research PLC | 1.94B | 1.11% | 78,089 | - |
| 282 | VIR | Vir Biotechnology, Inc. | 1.93B | -0.57% | 1,152,028 | 303.23M |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.92B | -0.60% | 714,062 | 27.59M |
| 284 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | -0.68% | 1,552,055 | 208.78M |
| 285 | ALVO | Alvotech | 1.90B | -1.12% | 535,385 | 494.61M |
| 286 | IMCR | Immunocore Holdings plc | 1.86B | -3.83% | 231,711 | 430.78M |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -1.83% | 208,175 | 1.13B |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.86B | 7.36% | 295,825 | - |
| 289 | SGRY | Surgery Partners, Inc. | 1.85B | 0.64% | 1,106,620 | 3.37B |
| 290 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 0.22% | 167,361 | 262.43M |
| 291 | CMPS | COMPASS Pathways plc | 1.84B | -0.15% | 792,896 | - |
| 292 | PSNL | Personalis, Inc. | 1.84B | 2.20% | 2,522,867 | 69.67M |
| 293 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -0.58% | 1,360,746 | 252.25M |
| 294 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 0.54% | 2,111,264 | 5.49M |
| 295 | INSP | Inspire Medical Systems, Inc. | 1.82B | 1.51% | 425,720 | 898.74M |
| 296 | SNDA | Sonida Senior Living, Inc. | 1.79B | -0.50% | 754,041 | 481.07M |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 0.47% | 2,796,286 | 59.51M |
| 298 | INBX | Inhibrx Biosciences, Inc. | 1.78B | -0.89% | 194,759 | 1.30M |
| 299 | FRNM | Freenome, Inc. | 1.75B | -3.49% | 621,948 | 35.41M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.72B | -0.79% | 344,309 | 106.69M |
| 301 | BRVE | Braveheart Bio, Inc. | 1.72B | 1.79% | 272,077 | - |
| 302 | SEPN | Septerna, Inc. | 1.72B | -0.14% | 199,663 | 98.88M |
| 303 | TYRA | Tyra Biosciences, Inc. | 1.71B | 15.25% | 1,864,288 | - |
| 304 | NVAX | Novavax, Inc. | 1.69B | -1.16% | 5,125,028 | 413.80M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.68B | -4.94% | 762,077 | 2.68B |
| 306 | ANAB | AnaptysBio, Inc. | 1.68B | -1.15% | 1,061,877 | 232.39M |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.67B | -2.42% | 521,574 | 105.60M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.66B | 5.50% | 243,503 | - |
| 309 | SLBT | SL Science Holding Limited | 1.64B | -8.57% | 68,505 | 3.27M |
| 310 | AAPG | Ascentage Pharma Group International | 1.64B | 1.47% | 5,099 | 94.61M |
| 311 | LBRX | LB Pharmaceuticals Inc | 1.59B | 3.83% | 205,855 | - |
| 312 | OMCL | Omnicell, Inc. | 1.57B | -1.29% | 873,103 | 1.25B |
| 313 | XERS | Xeris Biopharma Holdings, Inc. | 1.56B | -0.70% | 1,030,324 | 335.41M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.55B | -0.86% | 175,089 | 1.52B |
| 315 | INVA | Innoviva, Inc. | 1.54B | -0.09% | 563,384 | 440.00M |
| 316 | ARDT | Ardent Health, Inc. | 1.54B | 1.39% | 449,031 | 6.41B |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.53B | -0.73% | 296,876 | - |
| 318 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | -1.06% | 219,215 | 978.38M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.26% | 182,374 | - |
| 320 | APMD | Apnimed, Inc. | 1.52B | -1.29% | 233,021 | 120.15M |
| 321 | ABSI | Absci Corporation | 1.51B | 0.23% | 2,150,231 | 1.56M |
| 322 | AKTS | Aktis Oncology, Inc. | 1.50B | 1.50% | 159,246 | 10.06M |
| 323 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 3.03% | 11,494,472 | 717.00M |
| 324 | SDGR | Schrödinger, Inc. | 1.50B | -2.99% | 876,630 | 259.04M |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.50B | 0.51% | 593,952 | 1.86B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | 1.59% | 181,776 | 95.13M |
| 327 | AGL | agilon health, inc. | 1.49B | 2.34% | 125,896 | 5.92B |
| 328 | VOR | Vor Biopharma Inc. | 1.48B | 3.34% | 421,753 | - |
| 329 | CNMD | CONMED Corporation | 1.48B | -0.20% | 281,280 | 1.37B |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.46B | 1.29% | 1,495,145 | 815.05M |
| 331 | INNV | InnovAge Holding Corp. | 1.46B | -0.19% | 161,316 | 949.17M |
| 332 | LTGO | Latigo Biotherapeutics, Inc. | 1.46B | 2.49% | 227,437 | - |
| 333 | MAZE | Maze Therapeutics, Inc. | 1.46B | 1.31% | 273,265 | 20.00M |
| 334 | TRAX | First Tracks Biotherapeutics, Inc. | 1.45B | -4.82% | 456,212 | - |
| 335 | HROW | Harrow, Inc. | 1.44B | 0.73% | 229,010 | 275.59M |
| 336 | ALMS | Alumis Inc. | 1.44B | -2.29% | 3,077,953 | 7.40M |
| 337 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | -0.32% | 562,485 | - |
| 338 | REPL | Replimune Group, Inc. | 1.42B | -1.64% | 910,228 | - |
| 339 | ANRO | Alto Neuroscience, Inc. | 1.40B | -2.34% | 269,944 | - |
| 340 | OMDA | Omada Health, Inc. | 1.39B | 2.15% | 877,384 | 309.76M |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 2.80% | 752,100 | - |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | -2.59% | 1,363,462 | 1.04B |
| 343 | ODTX | Odyssey Therapeutics, Inc. | 1.38B | 8.94% | 268,950 | 99.00K |
| 344 | AZTA | Azenta, Inc. | 1.37B | 0.48% | 751,877 | 613.81M |
| 345 | OMER | Omeros Corporation | 1.37B | -0.84% | 892,179 | 38.42M |
| 346 | SVRA | Savara Inc. | 1.36B | - | 625,457 | - |
| 347 | MGTX | MeiraGTx Holdings plc | 1.33B | -0.57% | 491,060 | 397.50M |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | 0.94% | 991,442 | - |
| 349 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 2.35% | 104,336 | - |
| 350 | PNTG | The Pennant Group, Inc. | 1.33B | -1.40% | 174,306 | 1.10B |
| 351 | NUTX | Nutex Health Inc. | 1.32B | -2.25% | 142,242 | 846.72M |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.31B | 1.17% | 581,260 | 3.43B |
| 353 | IMTX | Immatics N.V. | 1.31B | 1.06% | 519,761 | 47.65M |
| 354 | MNKD | MannKind Corporation | 1.31B | 2.53% | 2,807,578 | 393.63M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.30B | 6.50% | 1,276,668 | 337.34M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.30B | 1.70% | 674,842 | 1.65B |
| 357 | MLTX | MoonLake Immunotherapeutics | 1.28B | -1.18% | 1,428,693 | - |
| 358 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.25% | 605,018 | - |
| 359 | AORT | Artivion, Inc. | 1.25B | -0.20% | 418,342 | 471.47M |
| 360 | JANX | Janux Therapeutics, Inc. | 1.24B | 2.22% | 700,767 | 24.00M |
| 361 | OPK | OPKO Health, Inc. | 1.22B | 1.86% | 2,350,122 | 587.90M |
| 362 | CERT | Certara, Inc. | 1.21B | -2.34% | 1,272,261 | 421.75M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -1.77% | 626,942 | - |
| 364 | CRON | Cronos Group Inc. | 1.20B | - | 493,685 | 179.09M |
| 365 | GDRX | GoodRx Holdings, Inc. | 1.19B | -1.42% | 854,831 | 785.23M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 0.90% | 91,476 | 804.27M |
| 367 | BVS | Bioventus Inc. | 1.18B | -2.02% | 502,332 | 581.85M |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -3.76% | 804,567 | 28.73M |
| 369 | KURA | Kura Oncology, Inc. | 1.18B | 0.76% | 1,313,518 | 77.23M |
| 370 | STAA | STAAR Surgical Company | 1.18B | -0.47% | 1,944,401 | 339.59M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | 2.35% | 250,655 | 1.04B |
| 372 | ATTO | Attovia Therapeutics, Inc. | 1.17B | 5.58% | 311,047 | 1.35M |
| 373 | SANA | Sana Biotechnology, Inc. | 1.15B | -1.79% | 1,239,802 | - |
| 374 | TDOC | Teladoc Health, Inc. | 1.14B | -2.94% | 2,957,364 | 2.49B |
| 375 | IVA | Inventiva S.A. | 1.11B | -1.24% | 1,350,616 | 7.94M |
| 376 | SLDB | Solid Biosciences Inc. | 1.10B | -1.63% | 495,296 | - |
| 377 | ENOV | Enovis Corporation | 1.07B | -4.33% | 1,886,848 | 2.30B |
| 378 | IRMD | IRADIMED CORPORATION | 1.07B | -3.63% | 233,146 | 86.34M |
| 379 | PCRX | Pacira BioSciences, Inc. | 1.05B | -0.94% | 481,690 | 746.16M |
| 380 | GMRS | GMR Solutions Inc. | 1.05B | 0.37% | 470,641 | 5.88B |
| 381 | OBX | Obsidian Therapeutics, Inc. | 1.04B | -1.58% | 140,109 | - |
| 382 | FTH | Faeth Therapeutics, Inc. | 1.03B | 2.69% | 275,245 | - |
| 383 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 1.21% | 633,217 | 59.00K |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.59% | 5,198,263 | 181.72M |
| 385 | GERN | Geron Corporation | 1.01B | 3.97% | 11,478,939 | 204.56M |
| 386 | CSTL | Castle Biosciences, Inc. | 1.01B | 0.80% | 187,714 | 357.28M |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | -0.88% | 1,044,611 | 41.47M |
| 388 | IMMX | Immix Biopharma, Inc. | 995.11M | 0.58% | 1,050,692 | - |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 986.03M | -2.77% | 650,128 | 730.02M |
| 390 | CADL | Candel Therapeutics, Inc. | 977.91M | -1.46% | 535,410 | - |
| 391 | SGP | SpyGlass Pharma, Inc. | 967.98M | -0.17% | 75,091 | - |
| 392 | ANL | Adlai Nortye Group Ltd. | 966.61M | 1.76% | 308,558 | 18.06M |
| 393 | QDEL | QuidelOrtho Corporation | 958.00M | 0.29% | 890,253 | 2.67B |
| 394 | WVE | Wave Life Sciences, Inc. | 957.65M | 3.40% | 3,030,257 | 65.37M |
| 395 | CBLL | CeriBell, Inc. | 948.71M | 0.61% | 223,606 | 101.96M |
| 396 | DSGN | Design Therapeutics, Inc. | 947.49M | 0.73% | 256,616 | - |
| 397 | ARDX | Ardelyx, Inc. | 941.93M | 1.89% | 2,982,307 | 450.89M |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 940.60M | 0.19% | 505,260 | - |
| 399 | ANNX | Annexon, Inc. | 923.25M | 0.62% | 1,227,540 | - |
| 400 | RIGL | Rigel Pharmaceuticals, Inc. | 909.15M | 0.35% | 104,916 | 276.79M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 908.22M | 3.70% | 1,746,642 | 8.22M |
| 402 | CBIO | Crescent Biopharma, Inc. | 893.69M | 2.35% | 239,693 | 11.88M |
| 403 | HELP | Cybin Inc. | 892.80M | 3.82% | 1,026,754 | - |
| 404 | CLYM | Climb Bio, Inc. | 891.41M | 6.37% | 1,495,263 | - |
| 405 | TBPH | Theravance Biopharma, Inc. | 886.77M | - | 160,550 | 104.31M |
| 406 | AVR | Anteris Technologies Global Corp. | 881.02M | 3.67% | 362,896 | 2.24M |
| 407 | SLN | Silence Therapeutics plc | 878.45M | -1.35% | 611,151 | 615.00K |
| 408 | BBNX | Beta Bionics, Inc. | 873.70M | -2.51% | 1,407,466 | 119.01M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 873.64M | 2.17% | 883,318 | - |
| 410 | AHCO | AdaptHealth Corp. | 865.83M | 1.09% | 2,614,641 | 3.36B |
| 411 | INMD | InMode Ltd. | 857.04M | 0.47% | 449,383 | 374.63M |
| 412 | HSTM | HealthStream, Inc. | 853.81M | -1.82% | 203,454 | 321.12M |
| 413 | GLAS | Glass House Brands Inc. | 836.87M | 3.26% | 482,892 | 176.98M |
| 414 | SIBN | SI-BONE, Inc. | 829.14M | -0.75% | 389,529 | 213.60M |
| 415 | FDMT | 4D Molecular Therapeutics, Inc. | 827.01M | 1.84% | 420,632 | 92.01M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 808.41M | 0.82% | 2,297,746 | 18.30M |
| 417 | NVCT | Nuvectis Pharma, Inc. | 797.92M | 0.49% | 117,164 | - |
| 418 | PHAR | Pharming Group N.V. | 797.03M | -2.01% | 5,489 | 366.48M |
| 419 | DBVT | DBV Technologies S.A. | 793.00M | -1.68% | 43,033 | 5.04M |
| 420 | MNPR | Monopar Therapeutics Inc. | 789.08M | -0.84% | 82,202 | - |
| 421 | AURA | Aura Biosciences, Inc. | 784.01M | 2.58% | 456,392 | - |
| 422 | VREX | Varex Imaging Corporation | 780.16M | -0.05% | 253,625 | 865.00M |
| 423 | AGMB | AgomAb Therapeutics NV | 777.13M | 6.41% | 245,268 | - |
| 424 | NGNE | Neurogene Inc. | 772.44M | 2.63% | 205,630 | 925.00K |
| 425 | COLL | Collegium Pharmaceutical, Inc. | 766.03M | -0.72% | 900,840 | 808.21M |
| 426 | MPLT | MapLight Therapeutics, Inc. | 765.28M | 4.79% | 550,841 | - |
| 427 | PHAT | Phathom Pharmaceuticals, Inc. | 754.59M | 4.97% | 1,236,691 | 239.66M |
| 428 | OCS | Oculis Holding AG | 751.28M | - | 124,346 | 1.45M |
| 429 | ASMB | Assembly Biosciences, Inc. | 745.20M | 1.30% | 156,451 | 74.85M |
| 430 | VSTM | Verastem, Inc. | 742.62M | 2.76% | 2,301,507 | 87.53M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 736.36M | -1.12% | 1,030,003 | 136.07M |
| 432 | GYRE | Gyre Therapeutics, Inc. | 727.39M | 6.52% | 56,021 | 109.82M |
| 433 | AHG | Akso Health Group | 726.49M | -2.95% | 2,649 | 13.83M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.96M | 0.90% | 117,609 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 703.92M | -0.70% | 829,288 | 389.32M |
| 436 | SOPH | SOPHiA GENETICS SA | 688.68M | -2.53% | 147,033 | 86.17M |
| 437 | SSII | SS Innovations International, Inc. | 683.31M | 0.59% | 21,763 | 52.40M |
| 438 | STTK | Shattuck Labs, Inc. | 681.47M | -2.44% | 677,720 | 1.00M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 680.62M | -0.51% | 4,428,567 | 4.64M |
| 440 | SGMT | Sagimet Biosciences Inc. | 680.02M | 0.18% | 1,250,058 | - |
| 441 | PHR | Phreesia, Inc. | 679.06M | -1.44% | 807,901 | 507.79M |
| 442 | BLSM | BlossomHill Therapeutics, Inc. | 674.47M | 9.94% | 168,700 | - |
| 443 | AQST | Aquestive Therapeutics, Inc. | 670.23M | -0.19% | 2,117,771 | 54.09M |
| 444 | MDXG | MiMedx Group, Inc. | 666.13M | 3.16% | 624,962 | 355.17M |
| 445 | ALT | Altimmune, Inc. | 665.25M | 5.88% | 4,871,948 | 31.00K |
| 446 | EVO | Evotec SE | 663.49M | -2.11% | 121,891 | 819.47M |
| 447 | PRME | Prime Medicine, Inc. | 658.25M | -0.27% | 1,619,295 | 4.07M |
| 448 | CRMD | CorMedix Inc. | 657.07M | -0.47% | 792,685 | 462.25M |
| 449 | DRUG | Bright Minds Biosciences Inc. | 656.57M | -4.20% | 93,008 | - |
| 450 | CTEV | Claritev Corporation | 651.29M | -1.69% | 70,568 | 994.67M |
| 451 | VALN | Valneva SE | 651.26M | -2.41% | 22,865 | 163.30M |
| 452 | OABI | OmniAb, Inc. | 629.54M | -8.84% | 1,703,966 | 38.46M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 628.27M | -4.95% | 346,230 | - |
| 454 | ANGO | AngioDynamics, Inc. | 628.25M | -1.75% | 477,943 | 320.17M |
| 455 | EOLS | Evolus, Inc. | 614.27M | 2.76% | 685,162 | 316.49M |
| 456 | ARVN | Arvinas, Inc. | 613.98M | 0.86% | 449,294 | 316.70M |
| 457 | CTKB | Cytek Biosciences, Inc. | 610.92M | - | 478,226 | 206.71M |
| 458 | TLRY | Tilray Brands, Inc. | 610.26M | -0.66% | 2,779,463 | 915.45M |
| 459 | PROK | ProKidney Corp. | 607.67M | 4.69% | 1,225,328 | 818.00K |
| 460 | STLN | Starling Oncology, Inc. | 604.36M | -0.67% | 466,592 | 587.24M |
| 461 | TECX | Tectonic Therapeutic, Inc. | 601.14M | 2.77% | 159,288 | - |
| 462 | ZURA | Zura Bio Limited | 597.02M | 5.95% | 1,389,462 | - |
| 463 | AUTL | Autolus Therapeutics plc | 596.20M | -2.18% | 1,836,148 | 117.39M |
| 464 | RGNX | REGENXBIO Inc. | 590.16M | -2.83% | 1,070,570 | 174.48M |
| 465 | CABA | Cabaletta Bio, Inc. | 588.32M | -0.29% | 4,891,095 | - |
| 466 | EIKN | Eikon Therapeutics, Inc. | 588.23M | -0.91% | 238,685 | - |
| 467 | WEAV | Weave Communications, Inc. | 586.39M | - | 2,193,921 | 257.79M |
| 468 | KIDS | OrthoPediatrics Corp. | 585.12M | -0.80% | 129,505 | 252.72M |
| 469 | DCTH | Delcath Systems, Inc. | 571.84M | - | 180,916 | 95.42M |
| 470 | BWAY | BrainsWay Ltd. | 565.49M | -2.48% | 49,628 | 60.70M |
| 471 | PRLD | Prelude Therapeutics Incorporated | 562.35M | 4.00% | 400,284 | 22.42M |
| 472 | SPRY | ARS Pharmaceuticals, Inc. | 558.89M | -0.88% | 852,847 | 116.93M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | 12.00% | 3,521,233 | - |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 547.08M | 0.54% | 168,542 | 251.00K |
| 475 | OVID | Ovid Therapeutics Inc. | 546.83M | 0.72% | 1,065,972 | 1.58M |
| 476 | CAPR | Capricor Therapeutics, Inc. | 546.51M | 1.29% | 2,555,651 | 11.13M |
| 477 | FLGT | Fulgent Genetics, Inc. | 542.88M | 0.41% | 224,998 | 323.93M |
| 478 | SCTX | Scribe Therapeutics Inc. | 542.77M | -6.95% | 148,196 | 33.30M |
| 479 | CERS | Cerus Corporation | 521.95M | 0.78% | 1,102,630 | 221.55M |
| 480 | ENTX | Entera Bio Ltd. | 519.43M | 1.69% | 606,922 | 42.00K |
| 481 | NPCE | NeuroPace, Inc. | 511.43M | 1.02% | 92,319 | 106.99M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 510.21M | -1.20% | 500,780 | - |
| 483 | SENS | Senseonics Holdings, Inc. | 509.18M | -2.73% | 425,544 | 48.55M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 485 | PRTA | Prothena Corporation plc | 504.13M | 2.29% | 383,926 | 54.53M |
| 486 | EDIT | Editas Medicine, Inc. | 496.06M | 4.87% | 1,390,650 | 47.01M |
| 487 | TCMD | Tactile Systems Technology, Inc. | 495.41M | -0.64% | 197,928 | 350.31M |
| 488 | PBYI | Puma Biotechnology, Inc. | 492.97M | 1.49% | 185,854 | 231.24M |
| 489 | EVH | Evolent Health, Inc. | 488.42M | 1.41% | 1,728,599 | 2.10B |
| 490 | RZLT | Rezolute, Inc. | 478.46M | 0.88% | 716,867 | - |
| 491 | KMDA | Kamada Ltd. | 477.32M | 3.26% | 160,808 | 191.85M |
| 492 | NRC | NRC Health | 476.23M | 1.32% | 141,619 | 140.00M |
| 493 | RLMD | Relmada Therapeutics, Inc. | 472.55M | 1.37% | 675,552 | - |
| 494 | SRTA | Strata Critical Medical, Inc. | 470.64M | -0.93% | 650,324 | 255.98M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.01M | - | 656,607 | 132.42M |
| 496 | AVIR | Atea Pharmaceuticals, Inc. | 467.59M | 0.17% | 204,138 | - |
| 497 | GALT | Galectin Therapeutics Inc. | 464.92M | 5.98% | 473,478 | - |
| 498 | CCCC | C4 Therapeutics, Inc. | 462.57M | 0.53% | 2,363,306 | 35.04M |
| 499 | OCGN | Ocugen, Inc. | 461.19M | 0.74% | 3,567,525 | 4.58M |
| 500 | SGHT | Sight Sciences, Inc. | 459.98M | -0.36% | 102,466 | 83.38M |